YOLFTbeta
BSF Enterprise Plc

BSF Enterprise Plc

BSFA · LSE · Healthcare / Biotechnology

1.00GBX-0.07 (-6.98%)

Price History

Full chart

Market Stats

Previous Close1.08
Open1.08
Day Range1.00 – 1.15
52-Week Range0.50 – 504.00
Volume1.90M
Market Cap2.29M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta3.64
50-Day Avg1.05
200-Day Avg1.47

About

BSF Enterprise Plc, together with its subsidiaries, develops and commercializes cell-based tissue engineering solutions in the United Kingdom and Hong Kong. The company acquires businesses in the biotechnology, marketing, and e-commerce sectors. It also engages in biotechnology start-up; lab-grown cornea and meat research; and development of skin technology. The company was incorporated in 2018 and is based in London, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Che John Connon
  • Employees14
  • Headquarters2 Portman Street, London, United Kingdom, W1H 6DU, UK
  • Websitehttps://bsfenterprise.com

Leadership

  • Mr. Geoffrey Robert Baker B.Com., L.L.B., M.B.A.Executive Chairman · b. 1956
  • Dr. Che John ConnonCEO, MD & Executive Director · b. 1972
  • Mr. Graham John William Duncan F.C.A.Chief Financial Officer · b. 1963
  • Mr. Ricardo GouveiaC.S.O
  • Mr. Marcelo BravoChief Business Officer

Financials

Income Statement

Currency: GBP2019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue-00012.94K57.82K52.84K
Growth (%)-----+346.77%-8.61%
Cost of Revenue--0160.50K99.50K84.47K180.31K
Gross Profit--0-160.50K-86.55K-26.64K-127.47K
Gross Margin-----668.78%-46.08%-241.25%
Operating Expense--58.22K766.82K1.48M1.76M1.51M
Operating Income-27.30K-93.76K-58.22K-927.32K-1.57M-1.79M-1.64M
Operating Margin-----12133.43%-3098.11%-3101.44%
EBITDA-27.30K-93.58K-58.00K-905.76K-1.46M-1.68M-1.10M
EBITDA Margin-----11276.53%-2904.73%-2090.71%
Net Income-94.40K-93.93K-58.43K-930.04K-1.50M-1.67M-1.11M
Net Income Margin-----11598.22%-2892.19%-2107.36%
Interest Expense0871072.11K11.96K9.62K2.92K
Interest Expense % of Total Revenue----92.44%16.64%5.54%

Balance Sheet

Currency: GBP2019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets552.20K455.40K401.45K4.03M5.26M3.50M3.01M
Total Liabilities35.22K32.26K36.63K449.47K401.63K305.07K289.02K
Total Equity516.99K423.14K364.82K3.58M4.86M3.19M2.72M
Cash552.20K445.06K359.87K1.06M2.32M637.66K149.02K
Total Debt---231.88K156.93K78.05K-
Net Debt-552.20K-445.06K-359.87K-829.65K-2.16M-559.61K-149.02K

Cash Flow

Currency: GBP2019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow-59.18K-107.14K-85.19K-667.24K-1.38M-1.59M-1.01M
Investing Cash Flow1.75K1.75K1.75K1.75K-64.85K-12.02K-9.92K
Financing Cash Flow611.38K1.37M1.37M1.37M2.70M-78.88K529.69K
Capital Expenditure10.62K10.62K310.62K64.85K12.02K10.36K
Free Cash Flow-59.18K-107.14K-85.19K-677.86K-1.44M-1.60M-1.02M
Dividends Paid---14.03K---
FCF to OCF100.00%100.00%100.00%101.59%104.70%100.76%101.03%
Dividend Paid to FCF----2.07%---

Key Statistics & Ratios

Market Cap2.29M
Enterprise Value3.02M
Trailing P/E0.00
Forward P/E0.00
Price / Sales44.91
Price / Book1.30
EPS-0.01
Book Value0.014
Revenue (TTM)51.07K
Gross Profit (TTM)-110.48K
EBITDA-1.37M
Profit Margin0.00%
Operating Margin-5382.97%
Return on Equity-55.01%
Return on Assets-25.64%
Shares Outstanding203.85M
Shares Float89.28M
Beta3.64
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Feb 27, 20261:12
  • Dec 18, 20251:12